GlaxoSmithKline(MX:GSKN)
MX$960.00+8.24 (+0.87%)
MX:GSKN
GlaxoSmithKline earnings date
MX$960.00
At close:+8.24 (+0.87%)
GlaxoSmithKline (GSKN) Q2 2019 Earnings Report
0 Followers
MX:GSKN Q2 2019 EPS Results
- Actual EPS
- MXN 14.32
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 13.88
MX:GSKN Q2 2019 Revenue Results
- Actual Revenue
- MXN 186.68B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +0.99%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 07/24/2019
- Time
- Before Open
- Conference Call
- Wednesday, July 24, 2019
MX:GSKN Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GSKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 13.76- | 12.96 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 24.7727.01 | 27.1 | -0.34% (-0.09) | |
| Jul 28, 2026 | 2026 (Q2) | 23.0624.96 | 22.99 | 8.58% (+1.97) | |
| Apr 29, 2026 | 2026 (Q1) | 21.4823.36 | 22.3 | 4.75% (+1.06) | |
| Feb 04, 2026 | 2025 (Q4) | 11.9412.96 | 10.81 | 19.97% (+2.16) | |
| Oct 29, 2025 | 2025 (Q3) | 23.3827.10 | 24.05 | 12.68% (+3.05) | |
| Jul 30, 2025 | 2025 (Q2) | 21.7822.99 | 20.74 | 10.85% (+2.25) | |
| Apr 30, 2025 | 2025 (Q1) | 19.4422.30 | 20.03 | 11.33% (+2.27) | |
| Feb 05, 2025 | 2024 (Q4) | 9.1010.81 | 13.69 | -21.06% (-2.88) | |
| Oct 30, 2024 | 2024 (Q3) | 21.4324.05 | 22.73 | 5.81% (+1.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

